GLP-1 Microdosing: Potential Benefits, Risks, and Medical Considerations
GLP-1 microdosing is an emerging, more gradual approach to metabolic support that uses significantly lower, often customized doses of GLP-1 medications. This is commonly discussed in ranges like semaglutide 0.125 to 0.25 mg weekly, to improve tolerability while supporting appetite control and insulin sensitivity for some individuals.